TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32930794

Group type: EXPERIMENTAL
Intervention: Cost-offset community-supported agriculture (CO-CSA) with a 50% subsidized share of local produce and nine complimentary nutrition classes
Number of subjects: 305
Study: 32815101

Group type: EXPERIMENTAL
Intervention: En bloc technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard technique (GlideScope‐first‐then‐ETT)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study: 36458916

Group type: EXPERIMENTAL
Intervention: Inhaled sargramostim (125 mcg twice daily for 5 days)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 122
Study: 32808151

Group type: EXPERIMENTAL
Intervention: Theory of Mind (ToM) intervention
Number of subjects: 141

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 141
Study: 34940806

Group type: EXPERIMENTAL
Intervention: 20-Valent Pneumococcal Conjugate Vaccine (PCV20)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: 13-Valent Pneumococcal Conjugate Vaccine (PCV13)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: 23-Valent Polysaccharide Vaccine (PPSV23)
Number of subjects: 1000
Study: 32132228

Group type: EXPERIMENTAL
Intervention: Comprehensive preschool curriculum (intervention)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Basic preschool curriculum (non-intervention)
Number of subjects: 150
Study: 34114608

Group type: EXPERIMENTAL
Intervention: Leaf expander (moderate continuous forces)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Rapid maxillary expander (RME)
Number of subjects: 56
Study: 34897453

Group type: EXPERIMENTAL
Intervention: Interactive video intervention (n = 50)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (n = 51)
Number of subjects: 101
Study: 33321405

Group type: EXPERIMENTAL
Intervention: Stigmatized language framing (emphasizing connection between China and COVID-19)
Number of subjects: 1451

Group type: EXPERIMENTAL
Intervention: Emphasizing economic impact of COVID-19
Number of subjects: 1451

Group type: COMPARATOR
Intervention: Messages emphasizing serious health risks of COVID-19
Number of subjects: 1451
Study: 32737091

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conscious sedation
Number of subjects: 84
Study: 35972855

Group type: EXPERIMENTAL
Intervention: Islatravir 0.25 mg with doravirine and lamivudine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Islatravir 0.75 mg with doravirine and lamivudine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Islatravir 2.25 mg with doravirine and lamivudine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combined islatravir groups
Number of subjects: 121

Group type: COMPARATOR
Intervention: DOR/3TC/TDF
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Islatravir (combined)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Islatravir with doravirine
Number of subjects: 121
Study: 33797665

Group type: EXPERIMENTAL
Intervention: Teacher participation in physical activity
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Physical Activity Reinforcement feedback
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Technical Instruction feedback
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Negative feedback
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Game Instruction
Number of subjects: 82
Study: 32006650

Group type: EXPERIMENTAL
Intervention: Methylene blue photodynamic therapy (MB-PDT) applied twice a week for four weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Topical betamethasone valerate ointment 100 mg applied three times per day for four weeks
Number of subjects: 20
Study: 36340698

Group type: EXPERIMENTAL
Intervention: Micronutrients
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 34795753

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Both interventions (nutrition and physical activity education)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Physical activity education
Number of subjects: 433

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 433
Study: 35358428

Group type: EXPERIMENTAL
Intervention: Triple therapy with artemether–lumefantrine plus amodiaquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Artemether–lumefantrine alone
Number of subjects: 0
Study: 33512796

Group type: EXPERIMENTAL
Intervention: L3-20 (20 Necator americanus larvae)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: L3-40 (40 Necator americanus larvae)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Hookworm-positive participants
Number of subjects: 54
Study: 35766202

Group type: EXPERIMENTAL
Intervention: Combined injection (intra and periarticular) of methylprednisolone acetate 40 mg and local anesthetic
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intraarticular injection of methylprednisolone acetate 40 mg and local anesthetic
Number of subjects: 60
Study: 33624730

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body mass)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cellulose (placebo)
Number of subjects: 16
Study: 35260100

Group type: EXPERIMENTAL
Intervention: Conventional plus PSMA PET imaging with intensified radiotherapy or surgery
Number of subjects: 776

Group type: COMPARATOR
Intervention: Conventional imaging
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Conventional plus PSMA PET imaging
Number of subjects: 776
Study: 34594197

Group type: EXPERIMENTAL
Intervention: Therapeutic massage robot (ADAMO)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control treatment (manual pressure release of myofascial trigger points)
Number of subjects: 44
Study: 35918731

Group type: EXPERIMENTAL
Intervention: Focused, expert medication management intervention including in-person consultation and virtual care follow-up.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care plus encouragement to use the Thrombosis Canada website.
Number of subjects: 0
Study: 34283694

Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR) initiated within 90 days of discharge
Number of subjects: 19376

Group type: COMPARATOR
Intervention: No Pulmonary Rehabilitation (Control)
Number of subjects: 19376

Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR)
Number of subjects: 19376
Study: 32700359

Group type: EXPERIMENTAL
Intervention: Misoprostol plus letrozole
Number of subjects: 120

Group type: COMPARATOR
Intervention: Misoprostol only
Number of subjects: 120
Study: 36118690

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 213
Study: 34311606

Group type: EXPERIMENTAL
Intervention: Single alcoholic beverage administration (placebo 0.00%, low 0.03%, moderate 0.06%, high 0.09%)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cumulative alcoholic administration method (placebo followed by three alcoholic drinks)
Number of subjects: 0
Study: 34001367

Group type: EXPERIMENTAL
Intervention: 18% CP and low RUP:RDP ratio (18CP-LR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 18% CP and high RUP:RDP ratio (18CP-HR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 22% CP and low RUP:RDP ratio (22CP-LR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 22% CP and high RUP:RDP ratio (22CP-HR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: High RUP:RDP ratio (HR)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 22% CP diets
Number of subjects: 48
Study: 32446921

Group type: EXPERIMENTAL
Intervention: Deep hypothermic circulatory arrest
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Selective antegrade cerebral perfusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double arterial cannulation
Number of subjects: 45
Study: 34621458

Group type: EXPERIMENTAL
Intervention: EBUS‐GS‐TBCB
Number of subjects: 59

Group type: COMPARATOR
Intervention: EBUS‐GS‐TBB
Number of subjects: 59
Study: 33064404

Group type: EXPERIMENTAL
Intervention: Working memory training
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Exergaming
Number of subjects: 69

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 69
Study: 35725538

Group type: EXPERIMENTAL
Intervention: Automated interactive text message program (n = 57)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Assessment control (n = 55)
Number of subjects: 112
Study: 33982320

Group type: EXPERIMENTAL
Intervention: Autogenous mineralized dentin matrix (MDM)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Xenograft granules
Number of subjects: 52
Study: 32279615

Group type: EXPERIMENTAL
Intervention: Topical silicone gel plus herbal extract gel (Allium cepa, Centella Asiatica, Aloe vera and Paper Mulberry)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Silicone gel
Number of subjects: 46
Study: 32829456

Group type: EXPERIMENTAL
Intervention: Virtual reality (VR) educational intervention for radiotherapy patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard nursing care process (control group)
Number of subjects: 60
Study: 32522282

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg x 1 for Day 1-3, 250 mg x 1 for Day 4-15) and Hydroxychloroquine (200 mg x 2 for Day 1-15)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Standard treatment + placebo
Number of subjects: 226
Study: 36045653

Group type: EXPERIMENTAL
Intervention: Coaching-based teleoccupational guidance (CTG)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard telerehabilitation
Number of subjects: 92
Study: 33152309

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 0
Study: 32276134

Group type: EXPERIMENTAL
Intervention: Blood triglyceride (TG) levels
Number of subjects: 15244

Group type: EXPERIMENTAL
Intervention: NonHDL‐c levels
Number of subjects: 15244

Group type: EXPERIMENTAL
Intervention: TC:HDL‐c ratio
Number of subjects: 15244

Group type: EXPERIMENTAL
Intervention: TG:HDL‐c ratio
Number of subjects: 15244

Group type: EXPERIMENTAL
Intervention: HDL‐c levels
Number of subjects: 15244

Group type: EXPERIMENTAL
Intervention: Genetic predicted blood TG level increase
Number of subjects: 15244
Study: 33090733

Group type: EXPERIMENTAL
Intervention: BMS-986166 (0.75-5.0 mg single dose and 0.25-1.5 mg/day repeated dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BMS-986166 (0.5 mg/day)
Number of subjects: 0
Study: 32080133

Group type: EXPERIMENTAL
Intervention: 3D printing technique
Number of subjects: 32

Group type: COMPARATOR
Intervention: Routine surgical treatment without 3D printing
Number of subjects: 32
Study: 35603798

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) with compression therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + compression therapy alone
Number of subjects: 40
Study: 33825020

Group type: EXPERIMENTAL
Intervention: Mouth rinsing
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dental spray
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Toothpaste gel
Number of subjects: 5

Group type: COMPARATOR
Intervention: Mouth rinsing and spray application
Number of subjects: 5
Study: 32699128

Group type: EXPERIMENTAL
Intervention: Video-feedback Intervention Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group ('dummy' intervention: telephone calls)
Number of subjects: 0
Study: 35799120

Group type: EXPERIMENTAL
Intervention: Emotion‐Focused Skills Training (EFST)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 120
Study: 33859411

Group type: EXPERIMENTAL
Intervention: Deep learning framework for analyzing Cytosponge-TFF3 test samples; specific dosage and duration not mentioned.
Number of subjects: 2331
Study: 32496600

Group type: EXPERIMENTAL
Intervention: Participatory organizational intervention (2 x 2 hr workshops over 1 year)
Number of subjects: 625

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 625
Study: 36002178

Group type: COMPARATOR
Intervention: White noise (control)
Number of subjects: 121
Study: 33373631

Group type: EXPERIMENTAL
Intervention: Image-only HWLs
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Text-only HWLs
Number of subjects: 1185

Group type: EXPERIMENTAL
Intervention: Image-and-text HWLs
Number of subjects: 1185

Group type: COMPARATOR
Intervention: No HWLs (control)
Number of subjects: 1185
Study: 32853634

Group type: EXPERIMENTAL
Intervention: Ustekinumab
Number of subjects: 2630
Study: 35360551

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) treatment
Number of subjects: 218

Group type: COMPARATOR
Intervention: Conventional therapy (Control group)
Number of subjects: 218
Study: 32781086

Group type: EXPERIMENTAL
Intervention: Aldafermin 1 mg daily for 24 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 35109643

Group type: EXPERIMENTAL
Intervention: Mobile application-based intervention training cognitive and meta-cognitive processes, three times a week for four weeks with remote therapist support
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 20
Study: 33498768

Group type: EXPERIMENTAL
Intervention: GV oocytes vitrified and IVM (Group GV‐Vit)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: GV oocytes IVM and vitrified at MII stage (Group MII‐Vit)
Number of subjects: 195

Group type: COMPARATOR
Intervention: GV oocytes IVM (Group not‐Vit)
Number of subjects: 195
Study: 32493267

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise program (IG)
Number of subjects: 204

Group type: COMPARATOR
Intervention: General exercise using elastic bands (CG)
Number of subjects: 204
Study: 36041353

Group type: EXPERIMENTAL
Intervention: Smartphone-assisted psychoeducation (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional pen-and-paper brochures (n = 30)
Number of subjects: 60
Study: 34649459

Group type: EXPERIMENTAL
Intervention: Dabigatran Etexilate
Number of subjects: 5390

Group type: COMPARATOR
Intervention: Acetylsalicylic Acid (Aspirin)
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: Age (10-year increase)
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: Body Mass Index (5-U increase)
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: NT-proBNP (N-terminal prohormone of brain natriuretic peptide)
Number of subjects: 5390

Group type: EXPERIMENTAL
Intervention: HAVOC and CHA2DS2-VASc scores
Number of subjects: 5390
Study: 35198410

Group type: EXPERIMENTAL
Intervention: 8-week therapist-assisted ICBT program with optional 4-week extension of support
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: 8-week therapist-assisted ICBT program with optional booster lesson
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Combined group with both extension and booster
Number of subjects: 434

Group type: COMPARATOR
Intervention: 8-week therapist-assisted ICBT program
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Extension and booster
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Overall ICBT program
Number of subjects: 434
Study: 32237205

Group type: EXPERIMENTAL
Intervention: Gynecologic cancer patients pre-radiation therapy
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Gynecologic cancer patients post-radiation therapy
Number of subjects: 157

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Gynecologic cancer patients (both pre and post RT)
Number of subjects: 157
Study: 35289688

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 96
Study: 33586087

Group type: COMPARATOR
Intervention: Traditional therapy with gustative‐thermic‐tactile stimulation (group A)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined program with neuromuscular electrical stimulation (group B)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 8
Study: 32867722

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lymph node metastasis (LNM) based on tumor diameter, T stage, and tumor differentiation.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lymph node metastasis (LNM) in the validation set.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Nomogram predictions compared to actual observations.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Decision curve analysis of the LNM nomogram.
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: Rates of lymph node metastasis (LNM) in different T stages.
Number of subjects: 796
Study: 34530882

Group type: EXPERIMENTAL
Intervention: Weekly SMS-questions about pain frequency and pain intensity
Number of subjects: 2892

Group type: COMPARATOR
Intervention: Control group (followed only by surveys)
Number of subjects: 2892
Study: 32700648

Group type: EXPERIMENTAL
Intervention: Young adults (18 to 39 years)
Number of subjects: 1871

Group type: COMPARATOR
Intervention: Other age groups
Number of subjects: 1871
Study: 33428439

Group type: EXPERIMENTAL
Intervention: Flat flexible shoes
Number of subjects: 164

Group type: COMPARATOR
Intervention: Stable supportive shoes
Number of subjects: 164
Study: 33079199

Group type: EXPERIMENTAL
Intervention: Vaccine with 50% efficacy
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Vaccine with 1 year protection duration
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Vaccine with 1 in 10,000 major adverse effects
Number of subjects: 1971

Group type: COMPARATOR
Intervention: FDA emergency use authorization
Number of subjects: 1971

Group type: COMPARATOR
Intervention: Vaccine from non-US country (China)
Number of subjects: 1971

Group type: COMPARATOR
Intervention: Vaccine from non-US country (UK)
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Endorsement from CDC
Number of subjects: 1971

Group type: EXPERIMENTAL
Intervention: Endorsement from WHO
Number of subjects: 1971

Group type: COMPARATOR
Intervention: Vaccine from China
Number of subjects: 1971
Study: 35776109

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation plus tamoxifen
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Ovarian stimulation plus letrozole
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard ovarian stimulation
Number of subjects: 162
Study: 33932684

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) intervention group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care group
Number of subjects: 60
Study: 32019154

Group type: EXPERIMENTAL
Intervention: Group 1 (95 µg/day folate from vegetables)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Group 2 (191 µg/day folate from vegetables)
Number of subjects: 48
Study: 36257214

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combined intervention (MBSR + Acupressure)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147
Study: 33749328

Group type: EXPERIMENTAL
Intervention: Eight sessions of web-based time management intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single-session web-based time management intervention
Number of subjects: 60
Study: 34902368

Group type: EXPERIMENTAL
Intervention: RT concurrent with temozolomide (TMZ) (75 mg/m2/d, 7 d/week) followed by adjuvant TMZ (CRT group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone (RT group, n = 18; 60 Gy in 30 daily fractions)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: RT concurrent with temozolomide (TMZ) (CRT group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone (RT group)
Number of subjects: 37
Study: 34447389

Group type: EXPERIMENTAL
Intervention: Pneumococcal protein-specific IgG titres measured at 1, 4, 9, 10, 23, and 24 months of age.
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: NTHi protein-specific IgG titres measured at 1, 4, 9, 10, 23, and 24 months of age.
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Correlation analysis of antibody titres and carriage density for both pathogens.
Number of subjects: 101
Study: 35673701

Group type: EXPERIMENTAL
Intervention: Portable pedal machine intervention (60 minutes per working day for 12 weeks)
Number of subjects: 32
Study: 33094725

Group type: EXPERIMENTAL
Intervention: Oxygen therapy (4 L/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (medical air)
Number of subjects: 20
Study: 32781010

Group type: EXPERIMENTAL
Intervention: Real 2 mA tDCS for 20 minutes
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 34739863

Group type: EXPERIMENTAL
Intervention: CDED plus partial enteral nutrition
Number of subjects: 44

Group type: COMPARATOR
Intervention: CDED alone
Number of subjects: 44
Study: 34558823

Group type: EXPERIMENTAL
Intervention: Nucleic acid polymers (NAPs) + tenofovir disoproxil fumarate (TDF) + pegylated interferon (pegIFN)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Lead-in TDF monotherapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: NAPs + pegIFN
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Follow-up after therapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: TDF monotherapy followed by NAP + pegIFN
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: End of therapy
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: End of therapy in 5 participants
Number of subjects: 23
Study: 36156115

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate vegan diet
Number of subjects: 164

Group type: COMPARATOR
Intervention: Vegetarian therapeutic diet
Number of subjects: 164
Study: 33998271

Group type: EXPERIMENTAL
Intervention: Factor V Leiden (FVL) carriers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-carriers of Factor V Leiden (FVL)
Number of subjects: 0
Study: 32331071

Group type: EXPERIMENTAL
Intervention: SEP-363856 (50 or 75 mg/d)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 245
Study: 32880252

Group type: EXPERIMENTAL
Intervention: Virtual reality self-training (VRS) program for 2 weeks, consisting of eight sessions.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Waiting list (WL) group, received no intervention.
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Virtual reality self-training (VRS) program for 2 weeks.
Number of subjects: 52